EP300 and cancer: The pathways highly enriched in EP300-mutated pan-cancer included cytokine–cytokine receptor interaction, cell cycle, p53 signaling, oocyte meiosis, type I diabetes mellitus, and Janus kinase (Jak)–signal transducer and activator of transcription (STAT) signaling (Figure 3).